Volume 40, Issue 9 p. i
FRONT COVER
Free Access

Front Cover, Volume 40, Issue 9

Natàlia Padilla

Natàlia Padilla

Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain

Search for more papers by this author
Alejandro Moles-Fernández

Alejandro Moles-Fernández

Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for more papers by this author
Casandra Riera

Casandra Riera

Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain

Search for more papers by this author
Gemma Montalban

Gemma Montalban

Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for more papers by this author
Selen Özkan

Selen Özkan

Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain

Search for more papers by this author
Lars Ootes

Lars Ootes

Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain

Search for more papers by this author
Sandra Bonache

Sandra Bonache

Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Search for more papers by this author
Orland Díez

Orland Díez

Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Area of Clinical and Molecular Genetics, University Hospital of Vall d’Hebron, Barcelona, Spain

Search for more papers by this author
Sara Gutiérrez-Enríquez

Corresponding Author

Sara Gutiérrez-Enríquez

Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Correspondence Xavier de la Cruz, Vall d’Hebron Institute of Research (VHIR), Passeig de la Vall d’Hebron, 119-129, 08035 Barcelona, Spain. Email: [email protected]

Sara Gutiérrez-Enríquez, Vall d’Hebron Institute of Oncology (VHIO), Cellex Center, C/Natzaret, 115-117, 08035 Barcelona, Spain. Email: [email protected]

Search for more papers by this author
Xavier de la Cruz

Corresponding Author

Xavier de la Cruz

Research Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR). Universitat Autònoma de Barcelona, Barcelona, Spain

Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

Correspondence Xavier de la Cruz, Vall d’Hebron Institute of Research (VHIR), Passeig de la Vall d’Hebron, 119-129, 08035 Barcelona, Spain. Email: [email protected]

Sara Gutiérrez-Enríquez, Vall d’Hebron Institute of Oncology (VHIO), Cellex Center, C/Natzaret, 115-117, 08035 Barcelona, Spain. Email: [email protected]

Search for more papers by this author
First published: 13 September 2019

Carli, Giorgio, Ferrero, Brusco, and Tartaglia have contributed equally to this work.

Graphical Abstract

Outside Front Cover: The cover image is based on the Special Article BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge by Natàlia Padilla et al., https://doi.org/10.1002/humu.23802. Cover design: Selen Özkan and Xavier de la Cruz.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.